<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35196887</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1477-0903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <PubDate>
              <Year>2022</Year>
              <Season>Jan-Dec</Season>
            </PubDate>
          </JournalIssue>
          <Title>Human &amp; experimental toxicology</Title>
          <ISOAbbreviation>Hum Exp Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of the AMPK signalling pathway in the aetiopathogenesis of ocular diseases.</ArticleTitle>
        <Pagination>
          <StartPage>9603271211063165</StartPage>
          <MedlinePgn>9603271211063165</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/09603271211063165</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">AMP-activated protein kinase (AMPK) plays a precise role as a master regulator of cellular energy homeostasis. AMPK is activated in response to the signalling cues that exhaust cellular ATP levels such as hypoxia, ischaemia, glucose depletion and heat shock. As a central regulator of both lipid and glucose metabolism, AMPK is considered to be a potential therapeutic target for the treatment of various diseases, including eye disorders.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review all the shreds of evidence concerning the role of the AMPK signalling pathway in the pathogenesis of ocular diseases.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">Scientific data search and review of available information evaluating the influence of AMPK signalling on ocular diseases.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Review highlights the significance of AMPK signalling in the aetiopathogenesis of ocular diseases, including cataract, glaucoma, diabetic retinopathy, retinoblastoma, age-related macular degeneration, corneal diseases, etc. The review also provides the information on the AMPK-associated pathways with reference to ocular disease, which includes mitochondrial biogenesis, autophagy and regulation of inflammatory response.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study concludes the role of AMPK in ocular diseases. There is growing interest in the therapeutic utilization of the AMPK pathway for ocular disease treatment. Furthermore, inhibition of AMPK signalling might represent more pertinent strategy than AMPK activation for ocular disease treatment. Such information will guide the development of more effective AMPK modulators for ocular diseases.[Formula: see text].</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shukal</LastName>
            <ForeName>Dhaval K</ForeName>
            <Initials>DK</Initials>
            <Identifier Source="ORCID">0000-0001-7086-7951</Identifier>
            <AffiliationInfo>
              <Affiliation>534329Iladevi Cataract and IOL Research Centre, Memnagar, Ahmedabad, Gujarat, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>76793Manipal Academy of Higher Education, Mangalore, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malaviya</LastName>
            <ForeName>Pooja B</ForeName>
            <Initials>PB</Initials>
            <Identifier Source="ORCID">0000-0002-1455-2063</Identifier>
            <AffiliationInfo>
              <Affiliation>534329Iladevi Cataract and IOL Research Centre, Memnagar, Ahmedabad, Gujarat, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>76793Manipal Academy of Higher Education, Mangalore, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharma</LastName>
            <ForeName>Tusha</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>534329Iladevi Cataract and IOL Research Centre, Memnagar, Ahmedabad, Gujarat, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Hum Exp Toxicol</MedlineTA>
        <NlmUniqueID>9004560</NlmUniqueID>
        <ISSNLinking>0960-3271</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005128" MajorTopicYN="N">Eye Diseases</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053858" MajorTopicYN="N">Metabolic Networks and Pathways</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AMPK</Keyword>
        <Keyword MajorTopicYN="N">cataract</Keyword>
        <Keyword MajorTopicYN="N">diabetic retinopathy</Keyword>
        <Keyword MajorTopicYN="N">glaucoma</Keyword>
        <Keyword MajorTopicYN="N">ocular disease</Keyword>
        <Keyword MajorTopicYN="N">retinoblastoma</Keyword>
        <Keyword MajorTopicYN="N">super kinases</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>5</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35196887</ArticleId>
        <ArticleId IdType="doi">10.1177/09603271211063165</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
